Sunakiment
Sunakiment is a humanized IgG1λ monoclonal antibody inhibitor targeting Thymic stromal lymphopoietin (TSLP) . Sunakiment can be used for inflammatory and immune system disorders like ulcerative colitis, rheumatoid arthritis and allergy and cancers research[1][2].
Product Specifications
CAS Number
2928519-36-0
Product Name Alternative
AZD-8630
UNSPSC
12352100
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]Ziegler SF, et al. The biology of thymic stromal lymphopoietin (TSLP) . Adv Pharmacol. 2013;66:129-55. |[2]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A01794-3-Fluoro647 100 µg/Vial
Anti-CD98/Slc3a2 Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details 134153-PE 100 µL
SYVN1 (Synovial Apoptosis Inhibitor 1, E3 Ubiquitin-protein Ligase Synoviolin, DER3, HRD1, KIAA1810) (PE)
Sign In for Pricing
View Details 
